Know your cancer.
ER, PR and HER2 status—and additional biomarker or genetic testing—can help shape which treatment roads are worth discussing.
Awareness matters. Metastatic breast cancer matters, too.
This October, Say YES to Hope is making room for the conversations that can get lost in a sea of pink—especially the realities, questions and treatment possibilities facing people living with metastatic breast cancer.
START HERE →ER, PR and HER2 status—and additional biomarker or genetic testing—can help shape which treatment roads are worth discussing.
If treatment has stopped working, a new biopsy, updated testing or a second review may reveal information that changes the conversation.
Medical oncology, radiation oncology, surgical oncology and interventional oncology may each have a role depending on where disease is and what matters most now.
Clinical trials can be a treatment road—not simply a last resort. TrialMagic can help organize possibilities worth exploring.
You deserve more than a ribbon. You deserve clear information, meaningful options, and people willing to help you find the next road.